Navigation Links
Sanofi-aventis Announces a Good Third Quarter Performance; Increase in 2007 full-year earnings growth guidance
Date:10/31/2007

ts for Human Use of the European Medicines Agency has also granted a positive opinion for the use of Taxotere(R) in Europe in this indication.

Ambien CR(TM) is showing strong resistance to the presence of Ambien(R) IR generics, with third-quarter net sales reaching $176 million in the United States. Net sales of Ambien CR(TM) for the nine months to end September 2007 totaled $561 million. As expected, net sales of Ambien(R) IR, which went off patent in the United States on April 20, 2007, fell significantly in the third quarter to euro 35 million, versus euro 352 million in the comparable period of 2006.

In Japan, sales of Myslee(R) (not consolidated by sanofi-aventis) rose by 8.7% in the third quarter to euro 29 million. Over the 9 months to end September, the product reported 11.2% growth, to euro 84 million.

In the United States, Eloxatin(R), the market-leading colorectal cancer treatment as adjuvant and in the metastatic phase, recorded net sales growth of 12.3% to euro 247 million. In Europe, the introduction of Eloxatin(R) generics is continuing, with several countries now affected including Germany, the United Kingdom, Italy, Spain and France. European sales of the product fell by 38.6% in the third quarter to euro 89 million. In the "Other countries" region, Eloxatin(R) recorded a fine performance, with net sales up 30.6% at euro 47 million.

Third-quarter net sales of Tritace(R) were down 25.3% at euro 168 million, reflecting the introduction of generics of the product in Canada.

Net sales of Acomplia(R) were euro 21 million in the third quarter and euro 58 million to end September. Results from clinical trials have shown that Acomplia(R) has a powerful effect in reducing HbA1c that is comparable with oral anti-diabetics. In addition, this effect is sustainable and associated with weight loss. Sanofi-aventis has decided to substantially broaden the ongoing development program in type 2 diabetes, which will include more than 5,70
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. FDA Gives Green Signal To Sanofi-Aventis SAs Cancer Drug Taxotere
2. Sanofi-Aventis sets the ball rolling for trials of H7N1 bird flu vaccine
3. Sanofi-Aventis Allows Thais To Make Plavix
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put ... muscle by up to 30lbs in less than 12 weeks ... Stan Stevenson, prompting an investigative review. , “Our Incredible ... diet formula that allows the body to pack on a ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Juvent Sports ... at the 2015 PGA Merchandise Show to bestow a ... incredible female amateur golfer, Arlene McKitrick. The award commemorated ... amateur golf tournament win. She won her first amateur ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Carinsurancesavings.biz has released ... accidental death and dismemberment insurance . , Purchasing an ... can be very advantageous. This type of rider provides benefits ... dismemberment can be considered a lesser form of life insurance. ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 JJsHouse.com is a ... dresses. Today, the business announces its latest collection of ... , “The most important issue is the wedding dress on ... thing in a woman’s life. Every bride wants to find ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... , TUESDAY, Feb. 8 (HealthDay News) -- Heavy drinking ... and is associated with long-term alcohol-related problems, researchers warn. ... drinking among older teens not only prevents immediate harm, ... the study authors pointed out. The researchers reviewed ...
... slightly higher in the offspring of male cancer survivors ... cancer, according to a study published online February 8th ... The increasing number of male cancer survivors ... their offspring. Although previous studies on children conceived naturally ...
... -- Researchers at the University at Buffalo have devised ... these medically important molecules from losing their shape and ... help speed the development of peptide-based drugs against diseases ... are simpler than existing techniques, one of which employs ...
... (HealthDay News) -- People whose genetic make-up produces lower levels ... at increased risk for major depression, says a new study. ... down after experiencing stressful events. This study found that ... cause them to produce lower levels of NPY have stronger ...
... (HealthDay News) -- Babies who are exposed to HIV at ... levels of antibodies to diseases such as whooping cough, tetanus ... samples from 104 HIV-infected and uninfected South African women and ... of the infants at 16 weeks of age. The samples ...
... beneath the surface, a team of researchers from the ... three South Korean institutions have identified two distinct neuronal ... treat a variety of skin diseases. One pathway produces ... a side effect. The findings, published in this ...
Cached Medicine News:Health News:Male cancer survivor offspring slightly higher risk of congenital birth abnormalities 2Health News:New techniques for stapling peptides could spur development of drugs for cancer 2Health News:Study Links Brain Molecule to Risk of Major Depression 2Health News:Mom's HIV May Lower Baby's Immunity to Other Diseases 2Health News:The hitch in the drug? The itch in the drug 2
(Date:1/23/2015)... Jan. 23, 2015  MedScope ( www.medscope.org ), the leading ... a 2015 Connected World magazine Connected World ... (mPERS), that can be used anywhere, anytime. The nomination ... In nominating MedScope, Landon Garner , ...
(Date:1/23/2015)... baseball,s all-time hits leader, is the new spokesperson for the ... has announced. "Pete,s a Hall of Famer in ... board with Myoflex," said Ducere Pharma Chief Executive Officer ... known across all generations. The passion and intensity that Pete ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... Careers, the leading online career service for postgraduate life ... for life science Master,s and PhD graduates October 5-6. ... with and interview alumni and degree candidates from more ... leaving their office. "We are excited about ...
... NATICK, Mass., May 10, 2011 Boston Scientific Corporation ... to the Asthma and Allergy Foundation of America (AAFA) ... of asthma management and treatment.  The Company,s support coincides ... According to AAFA, more than 20 million ...
Cached Medicine Technology:Online Career Service to Hold World's First Virtual Job Summit for Postgraduate Life Scientists 2Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 2Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 3Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation 4
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Bair Hugger Model 505 provides safe, quiet and effective warming to patients around the world....
Bair Hugger temperature management units are the only forced-air warming systems that can be used with an integrated, cost-effective method of fluid warming...
Provides outstanding patient warming and safety throughout the hospital and is nearly half the size and one-third the weight of earlier units....
Medicine Products: